Confidence in American Innovation

Thermo Fisher Investment Reinforces Confidence in American Innovation
  • Thermo Fisher’s commitment to U.S. manufacturing reflects our confidence that America will continue to lead the world in science and innovation.
  • As one of the largest manufacturers of medicines in the world, Thermo Fisher’s American manufacturing supports healthcare supply chain resilience and has a huge multiplier effect across the American economy.
  • By expanding our U.S. operations, Thermo Fisher ensures that medicines are developed and manufactured in America for decades to come.

Thermo Fisher Scientific will invest an additional $2 billion in America over the next four years to strengthen domestic manufacturing and accelerate R&D.

As one of the world’s largest manufacturers of medicines, Thermo Fisher enables biopharma companies to develop and produce their medicines in America.

These latest investments support a resilient U.S. healthcare supply chain and will have a strong multiplier effect across the American economy.

“Thermo Fisher’s commitment to U.S. manufacturing reflects our confidence that America will lead the world in science and innovation,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. “Thermo Fisher is proud to serve as a growth engine for the American economy.”   

The new investment includes $1.5 billion for U.S. manufacturing expansion and $500 million for high-impact R&D.

 

With 64 U.S. manufacturing operations located across 37 states, Thermo Fisher plays a key role in producing innovations that power the U.S. life sciences sector – from analytical instruments and specialty diagnostics to contract development and manufacturing services for pharmaceutical innovators. 

Government Relations Contact: 

 Media Contact:
Tim.Fenton@thermofisher.com media.relations@thermofisher.com

Related News

Back to top